Thymosin Alpha-1.

Thymosin Alpha-1 is a synthetic version of a naturally occurring thymic peptide originally isolated from thymosin fraction 5. With the molecular formula C₁₂₉H₂₁₅N₃₃O₅₅ and a molecular weight of 3108.3...

$53.00

Select Protocol

Lab Verified

Clinical Grade

PMID Cited

Mechanism of Action.

Published preclinical research has characterized the following molecular pathways and receptor interactions for Thymosin Alpha-1.

MyD88-dependent pathway

TLR Signaling

Thymosin Alpha-1 interacts with Toll-like receptors, activating MyD88-dependent signaling and NF-κB translocation in immune cell cultures.

TCR signaling enhancement

T-Cell Activation

Research indicates the peptide enhances T-cell receptor signaling and T-cell differentiation markers in lymphocyte cultures.

Evidence Based

Clinical Literature

View All Studies

Preclinical

Research review on Thymosin Alpha-1 molecular characterization.

Preclinical studies have characterized the molecular properties and receptor binding profiles of Thymosin Alpha-1 in standardized assay systems.

Preclinical

Thymosin Alpha-1 structure-activity relationship analysis.

Structure-activity relationship studies have examined the functional domains and binding characteristics of Thymosin Alpha-1 in cell-free and cell-based systems.

RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.

Continue Exploring